Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02230306
Title Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Acronym CoBRIM-B
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hussein Tawbi
Indications
Therapies
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST